Literature DB >> 27762197

The Corrona US registry of rheumatic and autoimmune diseases.

Joel M Kremer1.   

Abstract

The Corrona US national registry collects data concerning patient status from both the rheumatologist and patient at routine clinical encounters. Corrona has functioning disease registries in rheumatoid arthritis, psoriatic arthritis, spondyloarthropathies, psoriasis and inflammatory bowel disease. Corrona merges data concerning long-term effectiveness and safety, as well as comparative and cost effectiveness of agents to treat these autoimmune diseases.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27762197

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  17 in total

1.  Physician Prescribing Patterns and Risk of Future Long-Term Opioid Use Among Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study.

Authors:  Yvonne C Lee; Bing Lu; Hongshu Guan; Jeffrey D Greenberg; Joel Kremer; Daniel H Solomon
Journal:  Arthritis Rheumatol       Date:  2020-07       Impact factor: 10.995

2.  Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.

Authors:  Justin K Owensby; Lang Chen; Ronan O'Beirne; Eric M Ruderman; Leslie R Harrold; Joshua A Melnick; Monika M Safford; Jeffrey R Curtis; Maria I Danila
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-07       Impact factor: 4.794

3.  Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records.

Authors:  Yinzhu Jin; Joan E Landon; Whitney Krueger; Alexander Liede; Rishi J Desai; Seoyoung C Kim
Journal:  BioDrugs       Date:  2022-06-30       Impact factor: 7.744

4.  Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

Authors:  Dimitrios A Pappas; Robert A Gerber; Heather J Litman; David Gruben; Jamie Geier; Winnie D Hua; Connie Chen; Youfu Li; Joel M Kremer; John S Andrews; Jeffrey A Bourret
Journal:  Am Health Drug Benefits       Date:  2018-05

5.  Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.

Authors:  Dimitrios A Pappas; Joel M Kremer; Jenny Griffith; George Reed; Bob Salim; Chitra Karki; Vishvas Garg
Journal:  Rheumatol Ther       Date:  2017-08-24

6.  Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis.

Authors:  Leslie R Harrold; Ani John; George W Reed; Tmirah Haselkorn; Chitra Karki; YouFu Li; Jennie Best; Steve Zlotnick; Joel M Kremer; Jeffrey D Greenberg
Journal:  Rheumatol Ther       Date:  2017-09-21

7.  Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.

Authors:  Leslie R Harrold; Ani John; Jennie Best; Steve Zlotnick; Chitra Karki; YouFu Li; Jeffrey D Greenberg; Joel M Kremer
Journal:  Clin Rheumatol       Date:  2017-07-17       Impact factor: 2.980

8.  Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.

Authors:  Leslie R Harrold; Ying Shan; Sabrina Rebello; Neil Kramer; Sean E Connolly; Evo Alemao; Sheila Kelly; Joel M Kremer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2020-05-24       Impact factor: 2.631

9.  Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.

Authors:  Dimitrios A Pappas; Taylor Blachley; Steve Zlotnick; Jennie Best; Kelechi Emeanuru; Joel M Kremer
Journal:  Rheumatol Ther       Date:  2020-03-30

10.  Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis.

Authors:  Leslie R Harrold; George W Reed; Jennie Best; Steve Zlotnick; Joel M Kremer
Journal:  Rheumatol Ther       Date:  2018-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.